Health Robotics Announces i.v.STATION and i.v.SOFT Contract With Sandoz Canada (Novartis) and Sphynx

BOZEN, Sud-Tirol, Italy, June 7, 2010 - Health Robotics announced that its joint-venture Health Robotics Canada
Inc. (HRCI), Sandoz Canada Inc., and Sphynx Medical Inc. have all recently
signed a marketing agreement to expand into Canada the market presence of
i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated
sterile compounding of intravenous medications and parenteral nutrition to
hospitals.

This new Canadian marketing contract complements HRCI's recently
announced multi-faceted strategic agreement with McKesson, guaranteeing the
sale, manufacturing, installation, and support of i.v.STATION and i.v.SOFT in
Canada and the USA. Today and tomorrow, McKesson will showcase both products
at Booth 701 of the American Society of Health-System Pharmacists' Summer
Meeting (ASHP) in Tampa, Florida.

Gordon Meyer, Vice President, Hospital Division, Sandoz Canada Inc.
stated, "As the leader in injectable drugs in Canada, our objective at
Sandoz is to facilitate the safe and effective preparation and administration
of injectable medications to ensure patient safety. With this marketing
collaboration agreement with Sphynx Medical and HRCI, we hope to contribute
to the development of business solutions to help our customers cope with some
of the most interesting challenges in the hospital pharmacy."

Health Robotics and Sandoz Canada are committed to facilitate smooth
integration of Sandoz's market-leading injectable vials with HRCI's products,
ensuring that i.v.STATION and i.v.SOFT are optimized for Sandoz's vial
formats, vial sizes, vial labels, and specific gravity information, thus
reducing the time that Canadian hospitals experience in the installation and
implementation of i.v.SOFT and i.v.STATION [showcased last week by NBC News
Boston www1.whdh.com/video/player/?clipId=4834596].

"Everyone at Health Robotics is very proud to collaborate with
Sandoz/Novartis, the injectable market leader in Canada. Dynamic and
creative, Sandoz Canada has one of the highest growth rates among the largest
manufacturers of generic injectable pharmaceutical products in Canada,"
stated Werner Rainer, Health Robotics' CEO.

Denis Nadeau, President of Sphynx Medical Inc., concluded: "I foresee
that the introduction of i.v.STATION and i.v.SOFT will dramatically improve
the process of I.V. sterile preparations at Canadian hospitals, deriving at
least similar clinical and financial benefits that I witnessed in Canada when
I led the market introduction at M.E.D.S. of the first automated oral
compounding devices in our country 20 years ago."

About Sandoz Canada Inc.

With more than 209 molecules, Sandoz Canada offers one of the broadest
portfolios of generic products in Canada. Through product development and
innovation, Sandoz demonstrates its leadership by constantly adding to its
existing portfolio. Sandoz develops, produces, markets and distributes a wide
array of oral, topical, rectal, ophthalmic, and injectable generic products
in different formulations (suspension, solution, tablet, capsule, cream,
ointment, suppository, gelcap, transdermal patches) and various presentations
(ampoules, vials, bottles, mini bags). Through its ability to rise to the
numerous challenges inherent to the development of sterile generic products,
Sandoz Canada's Development Centre has built a reputation for excellence
within the Novartis group. Sandoz Canada employs about 800 people, mostly
based at its Boucherville facilities (South Shore of Montreal). For more
information, please visit www.sandoz.ca/site/en/index.shtml

About Sphynx Medical:

Founded in 1995, and located in Longueuil, Quebec, Sphynx Medical's main
focus is the importation and distribution of various innovative and high-tech
medical products such as Quidel Corporation's line of rapid detection tests
and Med-Logics's calibrated LASIK blades for laser surgeries. For more
information, please visit sphynxrobot.com/

About Health Robotics:

Health Robotics is the undisputed global leading supplier of
life-critical intra-venous medication robots, providing healthcare facilities
in 5 continents with robotics technology and software automation solutions.
Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM)
[non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding,
powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral
nutrition] have and will greatly contribute to ease hospitals' growing
pressures to improve patient safety, increase throughput and contain costs.
Through the effective and efficient production of sterile, accurate,
tamper-evident and ready-to-administer IVs, Health Robotics' solutions help
hospitals eliminate life-threatening drug-exchange errors, decrease other
therapy oversights and sterility risks, work more efficiently, reduce waste
and controlled substances' diversion, and diminish the gap between rising
patient volume/acuity and scarce nursing and pharmacy staff. For more
information, please visit www.health-robotics.com

    For additional information, please contact:

    Health Robotics S.r.l.
    Claudia Flaim, Marketing Coordinator
    +39-0471-200-372
    flaim@health-robotics.com

For additional information, please contact: Health Robotics S.r.l., Claudia Flaim, Marketing Coordinator, +39-0471-200-372, flaim at health-robotics.com